Is [18F]-2-fluoro-2-deoxy-d-glucose (FDG) scintigraphy with non-dedicated positron emission tomography useful in the diagnostic management of suspected metastatic thyroid carcinoma in patients with no detectable radioiodine uptake? (Q44599549)
Jump to navigation
Jump to search
scientific article published in October 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Is [18F]-2-fluoro-2-deoxy-d-glucose (FDG) scintigraphy with non-dedicated positron emission tomography useful in the diagnostic management of suspected metastatic thyroid carcinoma in patients with no detectable radioiodine uptake? |
scientific article published in October 2003 |
Statements
1 reference
Is [18F]-2-fluoro-2-deoxy-d-glucose (FDG) scintigraphy with non-dedicated positron emission tomography useful in the diagnostic management of suspected metastatic thyroid carcinoma in patients with no detectable radioiodine uptake? (English)
1 reference
Francesco Giammarile
1 reference
Zakia Hafdi
1 reference
Claire Bournaud
1 reference
Marc Janier
1 reference
Claire Houzard
1 reference
Claude Desuzinges
1 reference
Roland Itti
1 reference
Genevieve Sassolas
1 reference
Francoise Borson-Chazot
1 reference
1 October 2003
1 reference
1 reference
149
1 reference
4
1 reference
293-300
1 reference
Identifiers
1 reference
1 reference